
GC11497
Doramapimod
Also listed as BIRB 796 (Doramapimod)
BIRB 796 (Doramapimod) (BIRB 796) is an orally active, highly potent p38 MAPK inhibitor, which has an IC50 for p38α=38 nM, for p38β=65 nM, for p38γ=200 nM, and for p38δ=520 nM
ChemicalCAS285983-48-4MW527.66FormulaC31H37N5O3
- CAS number
- 285983-48-4
- Molecular weight
- 527.66
- Formula
- C31H37N5O3
- Solubility
- ≥ 26·4mg/mL in DMSO, ≥ 11·24 mg/mL in EtOH with ultrasonic
- InChIKey
- MVCOAUNKQVWQHZ-UHFFFAOYSA-N
- Catalogue number
- GC11497
- Brand
- GLPBIO
Computed properties PubChem CID 156422 · XLogP 5.7 · TPSA 80.7 Ų · H-bond donors 2
- XLogP
- 5.7
- TPSA
- 80.7 Ų
- H-bond donors
- 2
- H-bond acceptors
- 5
- Rotatable bonds
- 8
- Heavy atoms
- 39
SMILES CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NC3=CC=C(C4=CC=CC=C43)OCCN5CCOCC5
Computed descriptors from PubChem (CID 156422), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il